Literature DB >> 1356800

Presynaptic inhibition by clonidine of neurotransmitter amino acid release in various brain regions.

Y Kamisaki1, T Hamahashi, T Hamada, K Maeda, T Itoh.   

Abstract

The release of endogenous aspartic acid (Asp), glutamic acid (Glu) and gamma-aminobutyric acid (GABA) was investigated in synaptosomes prepared from various regions of the rat brain. The basal release of Asp, Glu and GABA from various regions was 12-35, 24-107 and 15-43 pmol/min per mg protein, respectively. Exposure to a depolarizing concentration of KCl (30 mM) resulted in 1.7 to 3.6-fold increases in Asp, Glu and GABA release. When clonidine (10(-4) M) was added to the perfusion medium, the K(+)-evoked overflow of both Asp and Glu was inhibited by 50-90% in the anterior cortex, thalamus and hypothalamus. Clonidine inhibited the K(+)-evoked Glu overflow by 30-40% in the posterior cortex and hippocampus. No significant effects were observed in the other brain regions (olfactory bulb, striatum, midbrain, cerebellum, pons, medulla oblongata). The inhibitory effects of clonidine were counteracted by an alpha 2-adrenoceptor antagonist, rauwolscine. The data suggest that the basal and K(+)-evoked release of Asp, Glu and GABA from nerve terminals is different in rat brain regions and that the presynaptic alpha 2-adrenoceptors which regulate the release of excitatory amino acids are mainly distributed in the anterior cerebral cortex, thalamus and hypothalamus of the rat brain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356800     DOI: 10.1016/0014-2999(92)90511-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  The effects of clonidine on discrete-trial delayed spatial alternation in two rat models of memory loss.

Authors:  Mark E Bardgett; Megan Points; Christian Ramsey-Faulkner; Jeff Topmiller; John Roflow; Travis McDaniel; Timberly Lamontagne; Molly S Griffith
Journal:  Neuropsychopharmacology       Date:  2007-09-19       Impact factor: 7.853

2.  Effects of taurine on GABA release from synaptosomes of rat olfactory bulb.

Authors:  Y Kamisaki; K Wada; K Nakamoto; T Itoh
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

3.  Presynaptic alpha2-adrenoceptors control excitatory, but not inhibitory, transmission at rat hippocampal synapses.

Authors:  S Boehm
Journal:  J Physiol       Date:  1999-09-01       Impact factor: 5.182

4.  The α2A -adrenoceptor suppresses excitatory synaptic transmission to both excitatory and inhibitory neurons in layer 4 barrel cortex.

Authors:  Minoru Ohshima; Chiaki Itami; Fumitaka Kimura
Journal:  J Physiol       Date:  2017-10-25       Impact factor: 5.182

5.  Changes in postnatal norepinephrine alter alpha-2 adrenergic receptor development.

Authors:  J D Sanders; H K Happe; D B Bylund; L C Murrin
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

6.  Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus.

Authors:  Giambattista Bonanno; Roberto Giambelli; Luca Raiteri; Ettore Tiraboschi; Simona Zappettini; Laura Musazzi; Maurizio Raiteri; Giorgio Racagni; Maurizio Popoli
Journal:  J Neurosci       Date:  2005-03-30       Impact factor: 6.167

7.  Icilin-evoked behavioral stimulation is attenuated by alpha₂-adrenoceptor activation.

Authors:  Jae Kim; Alan Cowan; Renata Lisek; Natalie Raymondi; Aaron Rosenthal; Daniel D Hirsch; Scott M Rawls
Journal:  Brain Res       Date:  2011-04-12       Impact factor: 3.252

8.  The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?

Authors:  J Srinivasan; Werner J Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-29       Impact factor: 3.000

Review 9.  Targeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive Disorders.

Authors:  Amy F T Arnsten; Min Wang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

10.  Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings.

Authors:  L Raiteri; E Luccini; C Romei; S Salvadori; G Calò
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.